The DTx Consortium is created to boost the adoption of digital therapies in Spain

Pharmaceutical, technology and telecommunications companies, startups and other entities have launched the DTx Consortium. It aims to advance the regulation of digital therapies and the definition of a sustainable financing model that guarantees their access to the Spanish healthcare market.

It’s the first Spanish multi-sector alliance focused on boosting the implementation of digital therapies in the national healthcare system. Spain is a country with enormous potential to adopt these types of solutions and thus take another step towards the digitalisation of the healthcare system, but to do so it is necessary to promote an effective regulatory model.

The members of the DTx Consortium are Barcelona Health HubAngelini Pharma EspañaBayerBoehringer IngelheimFerrerGSD HealthMerck EspañaOpinno, Pfizer EspañaIESE Business SchoolTeladoc Health, RocaJunyentUnlimited ThinkingVodafone Business, Vodafone Innovation EcosystemAmelia Virtual CareBraingazeLegit.Health and Onalabs Inno-Hub.

Read more about it here!